A new startup founded by a former Google DeepMind scientist is exiting stealth with $50 million in funding. Latent Labs is ...

Google DeepMind CEO Demis Hassabis said that DeepSeek’s AI model is probably China's most impressive work but noted that it ...

The changes come after consideration of the long-awaited Science System Advisory Group's (SSAG) first report by Sir Peter Gluckman. The Public Research Organisations will be grouped by area of focus.

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested ... This can be done in collaboration with ...

Isomorphic Labs, spun out from Google DeepMind in 2021, represents a growing trend of tech giants leveraging AI to streamline the traditionally lengthy and expensive drug development process.

Future of AI and science discussed by Google DeepMind CEO While the potential benefits of AI in science have been spoken about, the CEO of Google DeepMind also addressed the potential timeline of ...

Prior research has explored various strategies ... presenting opportunities for future advancements. Researchers from Google DeepMind, UC San Diego, and the University of Alberta introduced Mind ...

I sat down with Lila Ibrahim, who joined DeepMind, Google’s “engine room of innovation” in 2018, to discuss the promise of AI for scientific discovery among other areas. This interview has ...

(Bloomberg) — Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief ...

Recent studies suggest that artificial intelligence (AI) is increasingly being used in scientific research, especially in Google Scholar, but unfortunately, the AI-generated content is flooding ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer. “We’ll ...

Google's DeepMind ... who along with DeepMind scientist John Jumper shared the 2024 Nobel Prize in Chemistry with a U.S. professor for their research in forecasting protein structures.